INCR Stock Analysis: Buy, Sell, or Hold?
$3.89
+0.29 (+8.06%)
▲
5d:
+7.76%
30d:
-21.41%
90d:
+303.19%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (84%)
Quality Score
62/100
Position
SLIGHTLY LOW
30-Day Fair Range
$3.81 – $4.98
Position: SLIGHTLY LOW
Forward P/E & Valuation
6.2x
Next 12M consensus est.
Wall Street Target
$33.56
+832.2% upside
Options IV & Volume
30th pct IV
HIGH volume confirmation
Support / Resistance
$3.12 / $4.42
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: INCR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When INCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: INCR is currently trading at $3.89, which is considered slightly low relative to its 30-day fair value range of $3.81 to $4.98.
Technical Outlook: Technically, INCR is in a strong uptrend. Immediate support is located at $3.12, while resistance sits at $4.42. The stock is showing strong short-term momentum, up 8.1% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $33.56 (+832.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INCR is in a strong uptrend. Immediate support is located at $3.12, while resistance sits at $4.42. The stock is showing strong short-term momentum, up 8.1% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $33.56 (+832.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.81 -
$4.98
Company Quality Score
62/100
(BUY)
Options IV Signal
30th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
84.2%
Trading Range & Key Levels
30-Day Trading Range
$3.81 -
$4.98
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.41
(10.6%)
Support Level
$3.12
Resistance Level
$4.42
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 30th percentile)
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.1%)
- BULLISH: Trading 832.2% below Wall St target ($33.56)
- NEUTRAL: Bottoming setup forming (58/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
6.18
Wall Street Target
$33.56
(+832.2%)
Revenue Growth (YoY)
23.9%
Earnings Growth (YoY)
-84.7%
Profit Margin
-13.2%
Share INCR Analysis
Share this live INCR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (INCR)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jun 22, 2026
Daily AI digest
AI Retail Discussion Summary:
InterCure ($INCR) secured NIS 22 million in private placement financing led by pharma-focused hedge funds.
Key Retail Themes:
financing
hedge funds
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 2:30 PM ET
Data refreshes hourly during market hours. Next update: 3:30 PM
Data refreshes hourly during market hours. Next update: 3:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 33 SELL |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$687 | 52 HOLD |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 53 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive INCR Research Pages
